🇯🇵 Japan Clinical Trials Database
Search 55,000+ clinical trials conducted in Japan. Access comprehensive trial data including phases, sponsors, outcomes, and locations from UMIN-CTR & JAPIC. Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the Japan clinical trials database?
The Japan clinical trials database contains over 55,000 clinical trials registered in Japan through UMIN-CTR (University Hospital Medical Information Network Clinical Trials Registry) and JAPIC (Japan Pharmaceutical Information Center).
How do I search for clinical trials in Japan?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. Results include trials registered in Japanese registries and international trials conducted in Japan.
What regulatory body oversees clinical trials in Japan?
The Pharmaceuticals and Medical Devices Agency (PMDA) oversees clinical trials in Japan. Japan has unique regulatory pathways including SAKIGAKE designation for innovative therapies.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies navigate Japanese clinical research.
Are regenerative medicine trials included?
Yes, Japan is a leader in regenerative medicine research. The database includes trials for cell therapies, gene therapies, and other advanced therapies approved under Japan's unique regulatory framework.
How does Japan clinical trial data compare globally?
Japan is the third-largest pharmaceutical market globally. Japanese trials often focus on oncology, rare diseases, and regenerative medicine, with unique patient populations and regulatory requirements.
About This Database
This database provides free access to clinical trial data from Japan. Japan has unique regulatory pathways through PMDA including accelerated approval for regenerative medicine. Use this tool to research the Japanese market, find J-NDA opportunities, understand PMDA requirements, and track drug/device development in Asia's largest developed healthcare market.